Moderna Inc.

Latest Stories

In this July 27, 2020, file photo, Nurse Kathe Olmstead, right, gives volunteer Melissa Harting, of Harpersville, N.Y., an injection as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. A letter from federal health officials instructing states to be ready to begin distributing a vaccine by Nov. 1 — two days before the election — has met, not with exhilaration, but with suspicion among public health experts and others. (AP Photo/Hans Pennink, File)

Americans fear coronavirus vaccine will be based on politics over safety

By Tom Howell Jr. - The Washington Times

Dr. Anthony Fauci, director of the National Institute for Allergy and Infectious Diseases, speaks during a House Subcommittee on the Coronavirus crisis hearing, Friday, July 31, 2020, on Capitol Hill in Washington. (Kevin Dietsch/Pool via AP) ** FILE **

Dr. Anthony Fauci: ‘Unfortunate’ AstraZeneca had to pause vaccine trial

By David Sherfinski - The Washington Times

Michigan residents can participate in COVID-19 vaccine study

Associated Press

President Donald Trump speaks during a coronavirus briefing at Bioprocess Innovation Center at Fujifilm Diosynth Biotechnologies, Monday, July 27, 2020, in Morrisville, N.C. (AP Photo/Evan Vucci)

Trump: American ‘genius’ will unleash coronavirus vaccine in ‘record time’

By Tom Howell Jr. - The Washington Times

In this March 16, 2020, file photo, a pharmacist gives Jennifer Haller, left, the first shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. The world's biggest COVID-19 vaccine test got underway Monday, July 27, with the first of 30,000 planned volunteers. The experimental vaccine is made by the National Institutes of Health and Moderna Inc., and it's one of several candidates in the final stretch of the global vaccine race. (AP Photo/Ted S. Warren, File)

Virus vaccine put to final test in thousands of volunteers

By Tom Howell Jr. - The Washington Times

In this Tuesday, March 31, 2020, file photo, medical technicians handle a vial containing a nasal swab at a drive-thru testing site in Wheat Ridge, Colo., as a statewide stay-at-home order remains in effect in an effort to reduce the spread of the COVID-19 coronavirus. Home testing for coronavirus may sound like a good idea, but As of early April 2020, U.S. regulators say it's still too risky. (AP Photo/David Zalubowski)

Moderna reports positive data in first phase of coronavirus vaccine trial

By David Sherfinski and Dave Boyer - The Washington Times

Groups cross Ocean Boulevard on Saturday, May 16, 2020, in Myrtle Beach, S.C.. With hotels, beaches, shopping and restaurants reopening along the Grand Strand, tourist season kicked off this weekend despite coronavirus concerns. (Jason Lee/The Sun News via AP)

U.S. turns coronavirus corner on ‘very positive day’

By Dave Boyer, Tom Howell Jr. and David Sherfinski - The Washington Times

FILE - In this March 16, 2020, file photo, Neal Browning receives a shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. The vaccine by Cambridge, Massachusetts-based Moderna Inc., generated antibodies similar to those seen in people who have recovered from COVID-19 in a study of volunteers who were given either a low or medium dose. (AP Photo/Ted S. Warren, File)

Moderna: Early coronavirus vaccine results are encouraging

By MARILYNN MARCHIONE - Associated Press

Older Americans get chance to join virus vaccine study

By The Associated Press - Associated Press

FILE - In this Tuesday, March 3, 2020 file photo, Dr. Kizzmekia Corbett, left, senior research fellow and scientific lead for coronavirus vaccines and immunopathogenesis team in the Viral Pathogenesis Laboratory, talks with President Donald Trump as he tours the Viral Pathogenesis Laboratory at the National Institutes of Health in Bethesda, Md. Dozens of research groups around the world are racing to create a vaccine as COVID-19 cases continue to grow. (AP Photo/Evan Vucci)

Behind the scenes, scientists prep for COVID-19 vaccine test

By LAURAN NEERGAARD - Associated Press

This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2. Also known as 2019-nCoV, the virus causes COVID-19. The sample was isolated from a patient in the U.S. Dozens of research groups around the world are racing to create a vaccine as COVID-19 cases continue to grow. (NIAID-RML via AP)

National Institutes of Health coronavirus vaccine efforts center on ‘spike’ protein

By Lauran Neergard - Associated Press

Workers disinfect subway trains against coronavirus in Tehran, Iran, in the early morning of Tuesday, Feb. 25, 2020. Iran's government said Tuesday that more than a dozen people had died nationwide from the new coronavirus, rejecting claims of a much higher death toll of 50 by a lawmaker from the city of Qom that has been at the epicenter of the virus in the country. (Sajjad Safari/IIPA via AP)

Drugmaker readies possible coronavirus vaccine for testing

By The Associated Press - Associated Press